Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
By Jose A. Obeso, M. Rodríguez-Oroz, B. Benítez-Temiño, F. Blesa, J. Guridi, C. Marín, Manuel Rodríguez. Movement Disorders, 2008
661 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Neurology
View Paper: https://www.semanticscholar.org/paper/d481d870eccc2ee89c58a7545ac7a71a9db4ef9c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Neurology
Citations in the corpus
- Dopamine and Cognitive Control in Prefrontal Cortex. (2019, background): “Interestingly, dopamine gates actions and action sequences through projection to the striatum [166,167], an area strongly innervated by layer V prefrontal neurons.”
- Functional neuroanatomy of the basal ganglia. (2012, positive): “Overall, the basal ganglia are shifted toward inhibiting cortically aided movements by an increased activation of the STN– GPi network and reduced excitability in the direct cortico-putaminal-GPi projection (Obeso et al. 2008).”
- Oxidative Stress and the Central Nervous System (2017, neutral): “Neurodegenerative disorders commonly associatedwithmuscular, dementic, and cognitive deficits exhibit brain atrophy, neurofibrillary tangles, plaques, and aggregates as pathologic hallmarks of the disease (Kipps et al., 2005; Obeso et al., 2008; Gandhi and Abramov, 2012).”